Cardiac 82Rubidium PET/CT: initial European experience

Area of Science:

• Cardiovascular Imaging
• Nuclear Medicine
• Radiopharmaceutical Applications

Background:

• Positron Emission Tomography/Computed Tomography (PET/CT) offers advantages over traditional Single-Photon Emission Computed Tomography (SPECT) for myocardial perfusion imaging.
• Rubidium-82 (82Rb) is a positron-emitting isotope suitable for PET imaging, with a short half-life ideal for repeated studies.

Purpose of the Study:

• To describe the initial European clinical experience with Rubidium-82 (82Rb) PET/CT for myocardial perfusion imaging.
• To evaluate the feasibility, image quality, and diagnostic utility of 82Rb-PET/CT in a clinical setting.

Main Methods:

• A prospective study of the first 100 patients (mean age 60 years) undergoing 82Rb cardiac PET/CT.
• Imaging was performed during adenosine infusion (stress) and at rest, with a 5-minute acquisition time per phase.
• Image quality was assessed by nuclear medicine physicians using a standardized reporting system, and a segment-by-segment analysis (17-segment model) was performed.

Main Results:

• Excellent image quality was achieved, with 77% rated as good and 23% as adequate; no inadequate studies were reported.
• No significant difference in image quality was observed between obese and non-obese patients.
• Perfusion abnormalities were detected in 41% of patients (29% inducible ischemia, 12% myocardial infarction), with findings correlating well with coronary angiography in 28 out of 30 cases.

Conclusions:

• Rubidium-82 (82Rb) PET/CT enables rapid myocardial perfusion assessment with high image quality, even in obese individuals.
• The technique demonstrates good correlation with invasive angiography where available.
• 82Rb-PET/CT represents a significant advancement for radionuclide imaging in European cardiology and nuclear medicine practices.